What one share of Nephros holds
PFAS (a mixture of seven PFAS compounds including PFOA, PFOS, PFHxS, PFNA, PFHpA, PFBS, and PFDA), our portfolio of products is further enhanced with the ability to address a broad spectrum of emerging and persistent waterborne contaminants.
Nephros’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $1.86 |
|---|---|
| Profit | $0.16 |
| Cash and investments | $0.43 |
| Book value | $1.10 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2018 | $0.83 | −$0.50 | — | — | — | $0.53 |
| 2019 | $1.37 | −$0.45 | $0.00 | −$0.30 | — | $0.58 |
| 2020 | $0.94 | −$0.53 | $0.03 | −$0.79 | — | $1.27 |
| 2021 | $1.02 | −$0.41 | $0.00 | −$0.14 | — | $1.14 |
| 2022 | $0.97 | −$0.72 | $0.01 | −$0.33 | — | $0.54 |
| 2023 | $1.37 | −$0.15 | $0.01 | $0.07 | — | $0.79 |
| 2024 | $1.34 | $0.01 | $0.01 | −$0.05 | — | $0.81 |
| 2025 | $1.71 | $0.11 | — | — | — | $0.96 |
Common questions about Nephros
How much does one share of Nephros earn?
Over the last 12 months, each share of Nephros earned $0.16 of profit on $1.86 of sales, keeping about 8¢ of every $1 (profit margin).
Does Nephros pay a dividend?
Nephros didn’t pay a dividend over the last 12 months, according to its SEC filings.
What is Nephros’s book value per share?
Nephros’s book value is $1.10 per share: what would be left for each share if it sold everything at the values on its books and paid every debt, as of June 30, 2026.
How much cash and debt does each share of Nephros have?
Each share of Nephros has $0.43 of cash and investments, as of June 30, 2026.
Has Nephros bought back shares?
Nephros’s share count rose about 60% from 2018 to 2025. That dilution means each share owns a smaller slice of the company.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.